scispace - formally typeset
T

Tahmineh Motevasseli

Researcher at University of California, San Diego

Publications -  5
Citations -  18

Tahmineh Motevasseli is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Macular degeneration & Retinal. The author has an hindex of 1, co-authored 5 publications receiving 3 citations. Previous affiliations of Tahmineh Motevasseli include Shahid Beheshti University of Medical Sciences and Health Services.

Papers
More filters
Journal ArticleDOI

Side Effects of Brolucizumab.

TL;DR: In this article, a new anti-VEGF agent, brolucizumab, was approved by the U.S. Food and Drug Administration (FDA) in late 2019 for the treatment of wet age-related macular degeneration.
Posted ContentDOI

Assessing the validity of a cross-platform retinal image segmentation tool in normal and diseased retina.

TL;DR: Social Determinants of Health Data for Patients with Eye Conditions in a Nationwide Data Repository and the Eye Terrence Lee (MS3) are presented.
Journal ArticleDOI

Progress Evaluation in Eyes with Geographic Atrophy and Retina Pseudocyst.

TL;DR: Retinal pseudocysts can be seen overlying geographic atrophy in non-exudative age-related macular degeneration and would not increase the risk of GA progression and CNV.
Journal ArticleDOI

REPLACEMENT OF LIDOCAINE GEL WITH TOPICAL PROPARACAINE ANESTHESIA FOR ROUTINE INTRAVITREAL INJECTIONS: A Comparative Study.

TL;DR: 3. 5% lidocaine gel is not superior to 0.5% proparacaine drops alone during office based intravitreal injections as patients attained good pain control and excellent rates of overall satisfaction with proparacsine drops alone.